← Leaderboards
Aaron P Rapoport
University Of Maryland Baltimore
$1,728,369
Attributed
$2,368,282
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $338.6K · FY2005–18$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$2,368,282 · 4
By mechanism
R21$1,257,808 · 2
R01$959,869 · 1
P30$150,605 · 1
Top collaborators
- Michael D Kalos3 shared
- Eduardo Davila2 shared
- Bruce L. Levine1 shared
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Christopher V. Plowe$27,953,996
- James P. Nataro$22,975,369
- Myron Max Levine$22,681,817
- James E Galen$3,102,757
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsPreventImmuneMalignant NeoplasmsBaseTumor ImmunityImmune ResponseMultiple MyelomaTumorDesignCohortPeptidesPeptide VaccinesAutologousPublishingInfusion ProceduresB-LymphocytesIn VivoEpitopesDisease RemissionAdoptive TransferImmunotherapyAutologous Stem Cell TransplantationCancer Vaccines
Grant awards (13)
Tumor Immunology and Immunotherapy (TII)$48,776
P30 · FY2018 · CA · contact PI
Tumor Immunology and Immunotherapy (TII)$34,975
P30 · FY2018 · CA · contact PI
Tumor Immunology and Immunotherapy (TII)$11,110
P30 · FY2018 · CA · contact PI
Tumor Immunology and Immunotherapy (TII)$6,943
P30 · FY2018 · CA · contact PI
Tumor Immunology and Immunotherapy (TII)$48,801
P30 · FY2017 · CA · contact PI
Adoptive transfer of gene-modified autologous T-cells post-ASCT for myeloma$315,497
R01 · FY2014 · CA · contact PI
Adoptive transfer of gene-modified autologous T-cells post-ASCT for myeloma$305,741
R01 · FY2013 · CA · contact PI
Adoptive transfer of gene-modified autologous T-cells post-ASCT for myeloma$338,631
R01 · FY2012 · CA · contact PI
Immunotherapy after ASCT for MM Using hTERT Vaccination + Vaccine-primed T cells$139,842
R21 · FY2009 · CA · contact PI
Immunotherapy after ASCT for MM Using hTERT Vaccination + Vaccine-primed T cells$285,000
R21 · FY2008 · CA · contact PI
Immunotherapy after ASCT for MM Using hTERT Vaccination + Vaccine-primed T cells$285,000
R21 · FY2007 · CA · contact PI
Immune responses to T-cell expansion + PCV immunization$273,983
R21 · FY2005 · CA
Immune responses to T-cell expansion + PCV immunization$273,983
R21 · FY2004 · CA